Newsroom
September 9, 2014
A team of researchers and physicians at The University of Texas Health Science Center at San Antonio are leading a more than $1 million pilot trial to determine if drugs designed for heart attack survivors can benefit those suffering from life-threatening peripheral vascular disease.
August 14, 2014
Kelly Grimes, a graduate student in the lab of Rochelle Buffenstein, Ph.D., at the Health Science Center’s Barshop Institute for Longevity and Aging Studies, conducted the first studies of naked mole rat cardiovascular function.
March 31, 2014
UT Medicine San Antonio cardiologist, Manoj Panday, M.D., implanted a subcutaneous internal cardioverter-defibrillator (S-ICD) into a patient at University Hospital on March 31.
January 18, 2013
Funding for innovative technology allows early detection and prevention of heart failure without additional surgery
November 16, 2012
FDA expands approved use of artificial heart valve to more patients
September 17, 2012
In a window-lined, almost-new laboratory on the campus of the UT Health Science Center San Antonio, a team of biochemists will spend the next four years studying newly discovered causes of cardiovascular disease that could lead to new drugs designed to prevent or reduce the severity of heart ailments.